HomePosts Tagged "MustGrow Biologics Corp."

Under the agreement, MustGrow will distribute Adjuvants’ product line across Canada through its recently acquired Canadian sales and distribution division, NexusBioAg.

MustGrow Biologics Corp. a leading provider of biological and regenerative agriculture solutions, is pleased to announce a five-year exclusive distribution agreement was signed with Adjuvants Plus Inc. (“Adjuvants”), a Canadian regenerative agriculture company. Under the agreement, MustGrow will distribute Adjuvants’ product line across Canada through its recently acquired Canadian sales and distribution division, NexusBioAg. MustGrow also has a First Right of Refusal for distribution of Adjuvants’ product line the U.S. market.

This is MustGrow’s first additional product to be added to the existing NexusBioAg product line subsequent to closing the Company’s purchase of NexusBioAg in December 2024. This agreement marks a significant milestone for MustGrow and Adjuvants as they work together to bring innovative, sustainable agricultural solutions to the forefront of North American farming. The partnership reinforces a shared vision for regenerative agriculture and a commitment to enhancing crop productivity while preserving soil health for future generations.

The partnership strengthens MustGrow’s commitment to delivering innovative biological solutions to farmers while expanding its portfolio with Adjuvants’ patented microbial technology featuring Clonostachys rosea, a beneficial fungus that provides plant health and protection benefits (as described more fully below). The agreement includes four key products, with a particular focus on EndoFine® and EndoGuard®, which offer a host of advantages for various crops in North America, including: corn, soybean, edible beans, pulses, canola, cereals (i.e., wheat, barley, oats, and rye), fruits and vegetables, and potatoes.

These products complement MustGrow’s existing crop portfolio, sold in Canada under NexusBioAg, reinforcing the Company’s position as a leader in biological agriculture. The patented Clonostachys rosea technology has been rigorously tested in NexusBioAg’s BioAdvantage Trials Program (“BAT Program”) on multiple crops across Canada over the past two years, demonstrating significant yield increases. With regulatory approvals already in place, MustGrow is poised to launch these products in the Canadian market for the 2025 crop year as well as start the BAT program in the U.S. on fruits & vegetables, targeting California.

“Partnering with Adjuvants aligns perfectly with our vision of advancing sustainable agriculture and providing farmers with innovative biological solutions,” said Corey Giasson, President & CEO of MustGrow. “Through NexusBioAg, our sales and distribution division, we look forward to bringing these solutions to the market and strengthening our relationships with growers across Canada and potentially into the U.S.”

“Levering MustGrow’s distribution platform allows us to bring the benefits of EndoFine® and EndoGuard® to more farmers across Canada,” stated Bill Brown, President Adjuvants. “With a shared commitment to regenerative agriculture, we are confident that these biological solutions will provide long-term benefits to soil health and crop productivity.”

Under the agreement, MustGrow will distribute Adjuvants’

MustGrow is collaborating to bring its uniquely effective technologies to help address the global Fusarium wilt TR4 fungal disease in banana issue.

Canada based MustGrow Biologics Corp. announced that the company has accepted membership into the Global Alliance Against TR4 (https://iica.int/en/global-alliance), an international consortium of world-leading banana players committed to defeat Fusarium wilt TR4 (“TR4”), a fungal disease jeopardising the future of bananas.  MustGrow is collaborating to bring its uniquely effective technologies to help address this global issue, joining international banana leaders, including Bayer, Chiquita, Del Monte, Dole, and Fyffes.

“I celebrate the willingness of MustGrow to join forces in this endeavor to put an end to this hazard and contribute in this manner to the food security and the economy of several families involved in the banana value chain,” Gabriel Rodríguez Marqués, IICA Representative in Paraguay Executive Secretariat of the Global Alliance Against TR4.

The deadly disease pathogen TR4 has been wreaking havoc and ravaging the $25 billion global banana industry – with infected plantations experiencing 100 per cent loss and being quarantined for decades.  A flurry of apocalyptic media accounts is revealing a race to save bananas from extinction after the disease has left a trail of scorched banana plantations in its wake.

MustGrow vs. TR4

Under commercial partnership with Bayer, Bayer has the option to continue to build on MustGrow’s work in treating TR4.  MustGrow’s approach harnesses the natural defense mechanism of the mustard plant to develop organic, safe, and effective biofungicides and biopesticides to treat a variety of pests, fungus, and disease, including TR4.

MustGrow’s previously disclosed work has demonstrated 100 per cent control of TR4 in a laboratory setting of five different plate samples at five different application rates.  All 25 plates showed 100% disease control utilizing MustGrow’s biofungicide technology after a five-day period. In field trial settings, application of MustGrow’s biofungicide demonstrated positive dose response with reduced incidence and severity of TR4 symptoms in banana plants after 21 days. Importantly, even at higher application rates there was no damage or phytotoxic effects to the banana plants, allowing MustGrow to explore treating the banana plants directly, in addition to soil applications.

Sustainable innovations and green technologies are necessary to ensure agricultural production continues to address food safety and security as well as soil health. MustGrow’s rapidly developing solutions are focused on sustainable, safe, and effective, organic plant-based crop protection solutions that harness the mustard seed’s natural defense mechanism to treat diseases, pests and weeds.  MustGrow’s technology has shown consistent efficacy in multiple global regions, in multiple crops, in multiple applications, over multiple years.  The commercial development collaboration between Bayer and MustGrow demonstrates the importance of innovation in sustainable technologies in agricultural regions around the world.

MustGrow is collaborating to bring its uniquely